CPNE3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.55191440096314E-15 |
Normal-vs-Stage2 |
4.26149999954717E-07 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.62447832963153E-12 |
Stage1-vs-Stage2 |
8.567800E-01 |
Stage1-vs-Stage3 |
7.742700E-03 |
Stage1-vs-Stage4 |
1.044160E-04 |
Stage2-vs-Stage3 |
1.353000E-01 |
Stage2-vs-Stage4 |
3.207500E-02 |
Stage3-vs-Stage4 |
3.289400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
1.62436730732907E-12 |
Normal-vs-Asian |
1.985890E-04 |
Caucasian-vs-AfricanAmerican |
5.381800E-03 |
Caucasian-vs-Asian |
9.041400E-01 |
AfricanAmerican-vs-Asian |
3.493600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62436730732907E-12 |
Normal-vs-Female |
1.62525548574877E-12 |
Male-vs-Female |
1.327960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.96090049648024E-10 |
Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(81-100Yrs) |
2.16579999490207E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.132200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.872800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.197600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.626800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.985800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.500000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.977300E-03 |
Normal-vs-Grade 2 |
2.8270719099055E-12 |
Normal-vs-Grade 3 |
1.62436730732907E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
1.537830E-01 |
Grade 1-vs-Grade 3 |
6.419600E-03 |
Grade 1-vs-Grade 4 |
3.23089999998416E-06 |
Grade 2-vs-Grade 3 |
8.155800E-04 |
Grade 2-vs-Grade 4 |
1.2397000093145E-09 |
Grade 3-vs-Grade 4 |
4.374200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
9.80560077579185E-12 |
Normal-vs-ccB subtype |
<1E-12 |
ccA subtype-vs-ccB subtype |
2.483000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62447832963153E-12 |
Normal-vs-N1 |
3.93489996142193E-09 |
N0-vs-N1 |
2.045600E-01 |
|
|